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Optimal set of grid size and angular increment
for practical dose calculation using the dynamic
conformal arc technique: a systematic evaluation
of the dosimetric effects in lung stereotactic body
radiation therapy
Ji-Yeon Park1,2, Siyong Kim3, Hae-Jin Park1,2,4, Jeong-Woo Lee5, Yeon-Sil Kim6 and Tae-Suk Suh1,2*
Abstract
Purpose: To recommend the optimal plan parameter set of grid size and angular increment for dose calculations
in treatment planning for lung stereotactic body radiation therapy (SBRT) using dynamic conformal arc therapy
(DCAT) considering both accuracy and computational efficiency.
Materials and methods: Dose variations with varying grid sizes (2, 3, and 4 mm) and angular increments
(2°, 4°, 6°, and 10°) were analyzed in a thorax phantom for 3 spherical target volumes and in 9 patient cases.
A 2-mm grid size and 2° angular increment are assumed sufficient to serve as reference values. The dosimetric
effect was evaluated using dose–volume histograms, monitor units (MUs), and dose to organs at risk (OARs) for
a definite volume corresponding to the dose–volume constraint in lung SBRT. The times required for dose
calculations using each parameter set were compared for clinical practicality.
Results: Larger grid sizes caused a dose increase to the structures and required higher MUs to achieve the target
coverage. The discrete beam arrangements at each angular increment led to over- and under-estimated OARs
doses due to the undulating dose distribution. When a 2° angular increment was used in both studies, a 4-mm grid
size changed the dose variation by up to 3–4% (50 cGy) for the heart and the spinal cord, while a 3-mm grid
size produced a dose difference of <1% (12 cGy) in all tested OARs. When a 3-mm grid size was employed, angular
increments of 6° and 10° caused maximum dose variations of 3% (23 cGy) and 10% (61 cGy) in the spinal cord,
respectively, while a 4° increment resulted in a dose difference of <1% (8 cGy) in all cases except for that of one
patient. The 3-mm grid size and 4° angular increment enabled a 78% savings in computation time without making
any critical sacrifices to dose accuracy.
Conclusions: A parameter set with a 3-mm grid size and a 4° angular increment is found to be appropriate for
predicting patient dose distributions with a dose difference below 1% while reducing the computation time by
more than half for lung SBRT using DCAT.
Keywords: Dynamic conformal arc therapy, Grid size, Angular increment, Lung, Stereotactic body radiation therapy
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Background
Stereotactic body radiation therapy (SBRT) has been
employed to increase the local tumor control of lung
and liver cancer treatments [1,2]. Various techniques
related to the treatment planning, the beam delivery,
and the imaging have been developed to achieve a more
accurate and conformal dose distribution [3-6]. To effec-
tively deliver the conformal dose distribution to the
planning target volume (PTV) while sparing organs at
risk (OARs), an arc track-based beam irradiation tech-
nique and a multi-leaf collimator (MLC) for adjusting
the field shape are used to implement dynamic con-
formal arc therapy (DCAT) and volumetric modulated
arc therapy (VMAT).
DCAT can provide conformal dose distributions by
delivering doses with an MLC dynamically conforming
its shape to the beam’s-eye-view projections of the PTV
with relatively fast dose computation [3,7-9], while VMAT
delivers the optimized dose distribution using a small
beamlet-based intensity modulation by a combination of
several separated MLC segments per beam [9]. Even
though DCAT does not use intensity-modulated beams, it
can still be used to satisfy the conformity requirements of
planned doses [9,10]. However, contrary to the continuous
beam delivery with a rotating gantry in the DCAT imple-
mentation, a grid-based discretized dose calculation for a
number of beams with dose variation depending on their
angular increment can cause systematic dose errors.
Although a smaller grid size can yield a more accurate
and conformal dose calculation, particularly in regions
of high dose gradient, dose calculations using a finer
calculation grid size require a longer computational time
[11,12]. The number of control points determined by
the angular increment also influences the calculation
accuracy and time. It is critical to determine plan param-
eters to balance the dose calculation accuracy and the
computational time efficiency in order to maximize the
quality of the plan while minimizing the planning time
[11,13-15] for efficient clinical application of DCAT.
When several dose computations are needed to deter-
mine a more conformal dose distribution by verifying
the variation in dose distributions during a trial-and-
error-based forward plan optimization process, a com-
promise between accuracy and efficiency is inevitable in
DCAT planning [16]. An evaluation of the dosimetric
impact of planning parameters would serve as an
important step toward creating a SBRT plan using an
appropriate grid size and angular increment.
The purpose of this study was to determine the opti-
mal plan parameter set of values for the dose calculation
grid size and angular increment for lung SBRT using the
DCAT technique that will provide clinically acceptable
dose accuracy and efficient computational time. Dose
variations and computation times with different grid
sizes and angular increments were analyzed for spherical
tumors in thorax phantom image sets and patient com-
puted tomography (CT) images. A systematic evaluation
of the dose variations and the calculation time would
provide a guideline for selecting appropriate planning
parameters and estimating dose errors for DCAT.
Materials and methods
Planning system and dose calculation
Dose distributions for lung SBRT plans using DCAT
were calculated by the analytical anisotropic algorithm
(AAA) (v. 8.6.15, Varian Medical Systems, Palo Alto, CA)
in an Eclipse planning system (v. 8.6.17, Varian Medical
Systems). The dose distributions were calculated in the
planning system with 24 GB of RAM and a dual-core
processor running under the Microsoft Windows® 64-bit
operating system. We adopted a commonly used dose-
fractionation scheme of 48 Gy in 4 fractions for lung
SBRT [1] to estimate the delivered doses using CT
image sets of 3-mm thickness for the phantom and
patient studies.
Phantom study
To estimate the dose variation in the tumor volumes
and OARs with variable plan parameter sets (i.e., combi-
nations of a variable grid size and an angular increment),
3 spherical clinical target volumes (CTVs) with diame-
ters of 1, 2, and 3 cm and the OARs including the spinal
cord, the lung, and the heart were delineated in a thorax
phantom (002LFC, CIRS, Inc., Norfolk, VA). After aver-
aging the Hounsfield unit (HU) values of the CTVs
defined in selected patients for this study, the average
value of 75 HU was overridden to the CTVs in the
phantom to simulate dosimetric effects in the cases of
individual patients (Figure 1). To define PTVs with
diameters of 2 cm (S2), 3 cm (S3), and 4 cm (S4), a 5-mm
margin was added to each CTV with diameters of 1 cm,
2 cm, and 3 cm, respectively, in consideration of organ
motion and set-up misalignment.
When the numerical beams at every angular increment
are irradiated to cover the PTV with the prescribed dose,
a uniform dose distribution is created near the isocenter.
As the distance between the axes of adjacent beams
increases at regions far from the isocenter, the irradiated
and unirradiated regions are sectionalized according to
the angular increment. Because OARs of small volume
can be placed on or off the beam path according to the
distance from the field axis to the OAR, the predicted
OAR doses are varied according to the angular position
of the OAR with respect to the isocenter even in the
same plan. To evaluate whether the plan parameter sets
can provide an acceptable calculation accuracy of the
OAR doses for the diverse cases encountered in our
study, we delineated hypothetical OARs at different
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distances and angular positions from the isocenter. A set
of 8 different spinal cords having a relatively small
volume was arranged, as shown in Figure 1, with 4 of
them at a distance (ds) of 9 cm from the isocenter in the
axial plane and the other 4 at a distance of 11 cm from
the isocenter. Four hypothetical spinal cords at the same
distance were separated (clockwise) by 5°, 10°, and 20°
with respect to the one chosen as the 0° azimuthal angle.
These simulated spinal cords were denoted as Vds,Θ
where ds is the distance, and Θ is the azimuthal angle.
For example, V9,20 indicates the (hypothetical) spinal
cord volume located at a 9-cm distance and a 20°
azimuthal angle.
Patient study
Dose variations as a function of variable grid size and
angular increment were also evaluated to determine the
appropriate plan parameter sets in patient cases having
different volumes and positions of structures. Contrary
to the phantom study in which all the PTV volumes
were spherical, relatively irregularly shaped PTVs were
chosen for the patient study. A total of 9 lung SBRT
patient data sets were retrospectively selected. As the
patients for lung SBRT undergo four-dimensional (4D)
CT scanning to measure the motion range of tumors at
our institution, the internal target volume (ITV) was
defined using 4D CT images. The PTV was created by
adding a 0.5-cm margin in the axial plane and 1.0 cm-
margin in the longitudinal plane to the ITV following
the referenced SBRT protocol [1]. For all patients, the
PTV was smaller than an equivalent diameter (dequi) of
5.5 cm and located at more than 2 cm from the
bronchial tree [1], where dequi was defined as the diam-
eter of a sphere having the same volume as the PTV.
Because the dosimetric effects on OARs distant from
the isocenter can be varied by changing the field size for
PTV, the patients were divided into 3 groups based on
the dequi of the PTV: small (3 cm ≤ dequi < 3.5 cm) (G1),
medium (3.5 cm ≤ dequi < 4.5 cm) (G2), and large
(4.5 cm ≤ dequi ≤ 5.5 cm) (G3). In each group, 3 patients
with spinal cords proximal to the isocenter (ds < 6 cm),
at an intermediate position (6 cm ≤ ds < 10 cm), and
distant (10 cm ≤ ds) from the isocenter were included to
evaluate the dose variation according to the plan param-
eter sets.
Plan parameters and evaluation
To determine the optimal grid size and angular incre-
ment to achieve a fast dose calculation without com-
promising dose calculation accuracy, dose distributions
were calculated using grid sizes of 2, 3, and 4 mm and
angular increments of 2°, 4°, 6°, and 10° in both the phan-
tom and patient studies. The four angular intervals were
selected based on plan parameters for linac-based radio-
surgery and arc therapy [12,17]. Plan optimization that
allowed coverage of 95% of the PTV with the prescribed
dose in the same calculation volume was carried out.
The dosimetric effects of each plan parameter were
evaluated using the dose–volume histograms (DVHs)
and the variation in the OAR doses. Considering the
dose constraints in the SBRT protocol [1], the OAR
doses were evaluated at the same volume as the “Max
Point Dose” for serial tissue and the “Critical Volume
Dose Max” for parallel tissue. Because most of the primary
Figure 1 A phantom computed tomography (CT) image and delineated planning target volume (PTV) and organs at risk (OARs).
The clinical target volume (CTV) overridden with 75 Hounsfield Unit value, the PTV created by adding a 5 mm-margin to the CTV, and the OARs
(including the lung, the heart, and the spinal cord) were contoured on the phantom CT image sets. A set of 8 simulated spinal cord volumes
were placed in different distances with 4 located 9 cm from the isocenter, and the other 4 at 11 cm from it. When a line connecting the
isocenter and the original spinal cord in the phantom was chosen as the 0° azimuthal angle, and the other simulated spinal cords were
positioned at 0°, 5°, 10°, and 20° in the clockwise direction. Each volume is denoted as Vds,Θ, where ds is the distance from the isocenter to
each spinal cord, and Θ is the azimuthal angle.
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OARs in lung SBRT are classified as serial tissues except
for the normal lung in the SBRT protocol, the corres-
ponding normal lung dose at a volume of 1000 cc and the
maximum dose of other OARs were analyzed according
to the dose constraint in the four-fraction scheme as
shown in Table 1 [1]. We summarized the relative
variation in monitor units (MUs) and structure doses by
normalizing them with respect to values in a reference
plan using a 2-mm grid size and a 2° angular increment.
The reference MU and doses were presented as absolute
values. The computation times were compared to evaluate
the time efficiency for each of the dose calculations for an
SBRT plan.
A dose calculation uncertainty of less than 2% has
been recommended in inhomogeneous media to ensure
that the total uncertainty in dose delivery to patients is
less than 5% [18-20]. When the doses predicted by AAA
were delivered to a lung phantom, the total dose
uncertainty has been estimated to be approximately 4%
[20,21]. If we consider an uncertainty of 2.5%, caused by
patient set-up and organ motion during treatment, an
additional dose calculation uncertainty due to selecting
the large grid size and angular increment should be less
than 1.7% to meet the criteria of the total dose uncer-
tainty. A plan parameter set which yields a dose distribu-
tion with a dose difference less than 1% and reduced
calculation time could be judged as suitable for dose
calculations in DCAT, because other larger errors can
come into play in dose delivery to inhomogeneous
materials.
Results
Phantom study
The PTV and OARs showed dose variations according
to the plan parameter sets, the structure’s position with
respect to the isocenter, and the field sizes. Quantitative
changes in MUs and the dose variation in the PTV and
OARs are summarized in Table 2.
Dose differences due to the effects of grid size and an-
gular increment became more obvious in the DCAT
plan for the smaller PTV of S2. When the dose distribu-
tions calculated for different grid sizes and an angular
increment of 2° were compared in S2, the grid size of
4 mm required higher values of the MU and showed
higher Dmean of the PTV up to a maximum increase of
3% for the MU (> 50.0) and a 1% increase for the Dmean
(60.8 cGy) than that of the 2-mm grid size, respectively.
The maximum dose of the spinal cord and D1000cc of the
lung increased by 3% (19.6 cGy) and 5% (4.0 cGy), when
the large grid size of 4 mm and 10° angular increment
were used. The grid size of 3 mm led to a dose differ-
ence of less than 1% in the MU (< 14), PTV (< 6.4 cGy),
spinal cord (< 5.5 cGy), and heart (< 8.6 cGy). Although
the dose difference due to the grid size effect was diffi-
cult to discern in the DVH of the OARs, we could
observe that the DVH lines of the PTV shifted to the
right (i.e., toward the higher dose range) for all cases
tested, as the grid size increased (Figure 2).
When the same angular increment was used for dose
calculations with smaller grid sizes (i.e., a 4-mm grid
with a 10° increment vs. a 2-mm grid with a 10° incre-
ment), the largest grid size caused the maximum dose
difference of 4% (41.7 cGy) in the spinal cord in S4 and
4% (47.6 cGy) in the heart in S2. Even though the dose
calculation using a 3-mm grid size also caused an
increase in the MUs and average dose (Dmean) of the
PTV, the variations in the MUs and Dmean of the PTV
were less than 1%. The maximum dose differences due
to the grid size of 3 mm were respectively 3% (18.1 cGy)
and 1% (9.1 cGy) in the spinal cord at angular incre-
ments of 10° and 2°.
Dose undulation was observed in the calculated dose
distributions, particularly in low-dose regions. The dose
distribution estimated using 10° increments showed an
undulated isodose pattern at isodose levels lower than
30% for S3 [Figure 3(a)]. However, an angular increment
of 2° provides dose undulation at a 10% isodose level
[Figure 3(b)]. Dose undulation generated by discrete cal-
culation using every angular increment of the beam
caused over- and under-estimated OAR doses, as shown
in DVHs (Figure 4) and listed in Table 2. When a 2-mm
grid size was used for dose calculation, an angular incre-
ment of 10° predicted a 2% lower (14.5 cGy) and 9%
higher (69.1 cGy) maximum dose than a 2° increment in
the spinal cord. When the same grid size was used, the
large angular increment caused relative dose variation of
up to 12%, however, the absolute difference was 9.0 cGy.
While the differences for the number of MUs and the
PTV dose between a 2° angular increment and larger
angular increments increased as the grid size increased
in S2, the angular increment effect on the variation in
the number of MUs and the PTV dose value was rarely
shown (< 1 cGy) for the large PTV (Table 2).
The plan parameter set of a 3-mm grid size and an
angular increment of 4° was able to achieve a dose
difference of less than 1% in all OARs tested and in all
Table 1 Dose constraints for organs at risk in lung
stereotactic body radiation therapy [1], when the dose
scheme of 12 Gy in 4 fractions is used
Type Organs Max point dose
Serial tissue Spinal cord 26 Gy
Esophagus 30 Gy
Heart 34 Gy
Parallel tissue Organs Critical volume Critical volume
dose max
Lung (right + left) 1000 cc 12.4 Gy
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Table 2 Monitor units (MUs) and structure doses in the form of a ratio normalized to a reference value from the case
of a 2-mm grid size and 2° angular increment, when different plan parameter sets (grid sizes of 2 mm, 3 mm, and 4
mm, and angular increments of 2°, 4°, 6°, and 10°) were used in the thorax phantom for the cases of spherical targets
[S2 (2-cm diameter), S3 (3-cm diameter), and S4 (4-cm diameter)]
Grid size
(mm)
Angular
increment (°)
MU Structures
PTV
(Dmean)
Heart
(Dmax)
Normal lung
(D1000cc)
Spinal cord (Dmax)
V9,0 V9,5 V9,10 V9,20 V11,0 V11,5 V11,10 V11,20
S2 2 2 1.00
(1638)a
1.00
(50.37)b
1.00
(13.60)
1.00
(7.40)
1.00
(6.92)
1.00
(7.19)
1.00
(7.44)
1.00
(7.48)
1.00
(5.57)
1.00
(5.77)
1.00
(6.09)
1.00
(6.34)
4 0.99 1.00 1.00 1.12 1.00 1.00 1.00 1.00 1.00 1.01 0.99 1.00
6 0.99 1.00 1.00 1.12 1.01 1.01 1.01 1.02 1.03 1.00 1.00 1.02
10 0.99 1.00 1.00 1.11 1.05 1.07 1.00 1.04 1.09 1.06 1.07 1.06
3 2 1.01 1.00 1.01 1.00 1.01 1.00 1.01 1.01 1.01 1.01 1.00 1.00
4 1.00 1.00 1.01 1.12 1.00 1.01 1.00 1.00 1.01 1.01 1.00 1.00
6 1.00 1.00 1.00 1.12 1.01 1.01 1.01 1.02 1.03 1.01 1.00 1.01
10 1.00 1.00 1.00 1.12 1.05 1.04 1.00 1.03 1.10 1.06 1.07 1.06
4 2 1.03 1.01 1.04 1.05 1.02 1.03 1.02 1.03 1.03 1.03 1.03 1.02
4 1.01 1.00 1.02 1.16 1.01 1.01 1.01 1.01 1.02 1.01 1.01 1.00
6 1.01 1.00 1.03 1.16 1.01 1.03 1.01 1.01 1.02 1.01 1.01 1.02
10 1.01 1.00 1.04 1.16 1.05 1.06 1.01 1.05 1.10 1.07 1.08 1.07
S3 2 2 1.00
(1518)
1.00
(46.41)
1.00
(18.09)
1.00
(1.76)
1.00
(9.18)
1.00
(9.65)
1.00
(10.03)
1.00
(10.10)
1.00
(7.31)
1.00
(7.61)
1.00
(8.12)
1.00
(8.45)
4 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.00 1.00
6 1.00 1.00 1.00 0.99 1.01 1.00 1.01 1.01 1.01 1.02 1.01 0.99
10 1.00 1.00 1.00 0.99 1.01 1.00 1.02 0.99 1.03 1.09 1.01 1.05
3 2 1.00 1.00 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
4 1.00 1.00 1.00 1.01 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.00
6 1.00 1.00 1.00 0.99 1.01 1.00 1.00 1.01 1.01 1.02 1.01 0.99
10 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.99 1.03 1.09 1.01 1.04
4 2 1.01 1.00 1.01 1.02 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
4 1.01 1.00 1.02 1.03 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00
6 1.01 1.00 1.01 1.02 1.01 1.00 1.01 1.01 1.00 1.00 1.01 1.00
10 1.01 1.00 1.01 1.02 1.00 1.00 1.01 0.99 1.02 1.08 1.01 1.04
S4 2 2 1.00
(1454)
1.00
(45.00)
1.00
(23.03)
1.00
(3.13)
1.00
(11.42)
1.00
(11.96)
1.00
(12.37)
1.00
(12.50)
1.00
(9.00)
1.00
(9.37)
1.00
(9.98)
1.00
(10.38)
4 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.00 1.00
6 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.03 1.00 0.99 1.01
10 1.00 1.00 1.00 1.01 1.02 0.99 1.01 1.02 0.98 1.04 0.99 0.99
3 2 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
4 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
6 1.00 1.00 1.01 1.00 1.00 1.00 1.00 1.00 1.01 0.99 0.99 1.01
10 1.00 1.00 1.00 1.00 1.01 0.99 1.01 1.02 0.98 1.03 0.99 0.99
4 2 1.00 1.00 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
4 1.00 1.00 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
6 1.00 1.00 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
10 1.00 1.00 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
a) The reference MU value and b) the reference dose (Gy) in each case were presented in parentheses.
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PTV doses except for a normal lung exposed to a
dose of less than 90 cGy in the phantom study for all
PTV sizes.
Patient study
The larger grid sizes caused PTV dose increases of less
than 1%, corresponding to average values of 7.3 ± 3.7 cGy
for a 3-mm grid and 26.2 ± 6.7 cGy for a 4-mm grid.
The increases in the number of MUs were less than
1% (5.9 ± 2.3) and 2% (19.8 ± 5.2), respectively. The
variations in the number of MUs and of the PTV and
OARs doses are shown in Table 3. However, the
number of MUs and the PTV doses were presented
according to only the grid sizes by averaging each
value at different angular increments, because the an-
gular increment effect on the variation in the number
of MUs (<1) and on the PTV doses (< 1 cGy) was
insignificant.
Although the smallest angle of 2° was used, the 4-mm
grid size caused a dose increase of up to 2% (55.3 cGy)
in the heart and 2% (46.5 cGy) in the spinal cord. The
largest dose variation caused by the 3-mm grid size was
less than 1% (21.2 cGy) in the spinal cord, as the same
Figure 2 Dose–volume histograms for grid sizes of 2 mm, 3 mm,
and 4 mm in the plan for S2. Each plan was optimized to fully cover
95% of the planning target volume with the prescribed dose.
Figure 3 Undulated dose distributions in an axial plane for the case of S3. Doses were predicted for the spherical planning target volume
with a diameter of 3 cm using a 2-mm grid size and angular increments of (a) 10° and (b) 2°.
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angular increment was used (i.e., a 2-mm grid with a 10°
increment vs. a 3-mm grid with a 10° increment). OAR
doses were also influenced by the organ position with
respect to the isocenter and the beam geometry, as can
be seen in the variation in the isodose lines according to
the angular increment (Figure 5). While the angular
increment of 10° caused the dose difference of 4%
(38.4 cGy) to the spinal cord for the distance case (G1),
the angular increment effect only had a slight effect
(< 5.0 cGy) on the spinal cord located relatively close
to the isocenter, when the 2-mm grid size was used.
The esophagus showed a dose difference from less than
1% to 5% (45.8 cGy) under the larger angular increment,
whereas the dose variation in the normal lung dose was
less than 5 cGy. When the grid size and angular increment
were respectively smaller than 3 mm and 6°, the OAR
dose was predicted to have a dose difference of less than
10 cGy (1%) except for the heart, which is exposed to less
than 70 cGy.
Calculation time
We were able to reduce the calculation time by averages
of 53 ± 1% and 68 ± 1% in the phantom study and 57 ± 3%
and 73 ± 2% in the patient study by using the 3-mm and
4-mm grid sizes (Table 4), respectively, when the same an-
gular increment was used. Using the angular increments
Figure 4 Dose–volume histograms for the spinal cord at V11,0. The volume is located at 11 cm-distance from the isocenter at a 0° azimuthal
angle. Histograms are drawn according to the applied angular increments (2°, 4°, 6°, and 10°) in the spherical planning target volume for (a) S2
(2-cm diameter) and (b) S4 (4-cm diameter).
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Table 3 Monitor units (MUs) and structure doses in the form of a ratio normalized to a reference value from the case
of a 2-mm grid size and 2° angular increment, when different plan parameter sets (grid sizes of 2 mm, 3 mm, and 4
mm, and angular increments of 2°, 4°, 6°, and 10°) were used in patient groups divided according to the equivalent
diameter (dequi) of the planning target volume (PTV)
Patient ΔAngle/
ΔGrid
MU PTV
(Dmean)
Heart (Dmax) Normal Lung (D1000cc) Cord (Dmax) Esophagus (Dmax)
2° 4° 6° 10° 2° 4° 6° 10° 2° 4° 6° 10° 2° 4° 6° 10°
(a) G1
a
Proximal
case
2 mm 1.00
(1777)b
1.00
(50.32)c
1.00
(0.21)
1.00 1.00 1.00 1.00
(2.99)
1.00 1.00 1.00 1.00
(18.03)
1.00 1.00 1.00 1.00
(16.01)
1.00 1.00 1.00
3 mm 1.00 1.00 1.00 1.00 0.99 0.99 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.99
4 mm 1.02 1.01 1.00 1.00 0.99 0.99 1.03 1.03 1.03 1.03 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.00
Intermediate
case
2 mm 1.00
(1725)
1.00
(51.33)
1.00
(11.49)
1.00 1.00 1.02 1.00
(2.00)
1.01 1.00 0.97 1.00
(9.37)
1.00 1.01 1.02 1.00
(11.54)
1.00 1.00 1.03
3 mm 1.00 1.00 1.00 1.00 1.00 1.02 1.01 1.01 1.01 0.98 1.00 1.00 1.01 1.02 1.00 1.00 1.00 1.03
4 mm 1.01 1.01 1.01 1.01 1.01 1.02 1.03 1.03 1.03 1.00 1.00 1.00 1.01 1.02 1.01 1.01 1.01 1.03
Distant case 2 mm 1.00
(1767)
1.00
(51.09)
1.00
(27.57)
1.00 1.00 1.00 1.00
(3.61)
1.00 0.99 1.00 1.00
(8.14)
1.00 1.01 1.04 1.00
(10.23)
1.00 1.00 0.99
3 mm 1.01 1.01 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.00 1.01 1.00 1.04 1.00 1.00 1.00 0.99
4 mm 1.02 1.02 1.02 1.02 1.02 1.02 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.04 1.01 1.01 1.01 1.00
(b) G2
d
Proximal
case
2 mm 1.00
(1542)
1.00
(51.25)
1.00
(0.34)
1.00 1.00 1.00 1.00
(9.38)
1.00 1.00 1.00 1.00
(25.31)
1.00 1.00 1.00 1.00
(20.57)
1.00 1.00 1.00
3 mm 1.00 1.00 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00
4 mm 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.02 1.02 1.02 1.02 1.01 1.01 1.01 1.01
Intermediate
case
2 mm 1.00
(1558)
1.00
(51.08)
1.00
(12.05)
1.00 1.00 1.01 1.00
(1.11)
1.00 1.00 1.00 1.00
(11.19)
1.00 1.00 1.02 1.00
(8.56)
1.00 1.01 1.05
3 mm 1.00 1.00 1.01 1.00 1.00 1.02 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.02 1.00 1.00 1.01 1.05
4 mm 1.01 1.01 1.01 1.01 1.01 1.02 1.03 1.03 1.03 1.02 1.02 1.01 1.01 1.02 1.01 1.01 1.02 1.05
Distant case 2 mm 1.00
(1658)
1.00
(50.68)
1.00
(31.91)
1.00 1.00 0.99 1.00
(1.09)
1.00 1.00 1.00 1.00
(5.54)
1.00 1.00 1.04 1.00
(6.66)
1.00 1.00 1.06
3 mm 1.01 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.00 1.01 1.00 1.04 1.01 1.01 1.00 1.05
4 mm 1.01 1.01 1.01 1.01 1.01 1.00 1.03 1.03 1.03 1.03 1.01 1.01 1.01 1.05 1.01 1.01 1.01 1.05
(c) G3
e
Proximal
case
2 mm 1.00
(1625)
1.00
(52.00)
1.00
(20.55)
1.00 1.00 1.00 1.00
(6.75)
1.00 1.00 1.01 1.00
(24.96)
1.00 1.00 1.00 1.00
(14.41)
1.00 1.00 1.00
3 mm 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
4 mm 1.01 1.00 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.01 1.02 1.02 1.02 1.02 1.00 1.00 1.00 1.00
Intermediate
case
2 mm 1.00
(1506)
1.00
(50.94)
1.00
(16.36)
1.00 1.00 1.01 1.00
(3.82)
1.00 1.00 1.00 1.00
(15.93)
1.00 1.00 1.01 1.00
(16.00)
1.00 1.00 1.01
3 mm 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.01 1.00 1.00 1.00 1.00
4 mm 1.01 1.01 1.01 1.01 1.01 1.02 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00
Distant case 2 mm 1.00
(1566)
1.00
(52.07)
1.00
(0.70)
1.00 1.00 1.00 1.00
(6.23)
1.00 1.00 1.01 1.00
(12.61)
1.00 1.01 1.03 1.00
(18.42)
1.00 1.00 1.00
3 mm 1.00 1.00 0.98 0.98 −0.98 0.98 1.00 1.00 1.00 1.01 1.00 1.00 1.01 1.03 1.00 1.00 1.00 1.00
4 mm 1.01 1.00 0.98 0.98 −0.98 0.98 1.00 1.00 1.00 1.01 1.00 1.00 1.01 1.03 1.00 1.00 1.00 1.00
a) The patient group meeting the criteria of the PTV size, 3 cm ≤ dequi < 3.5 cm. Each group includes three patients with different spinal cords distances (ds) from
the isocenter as follows: proximal (ds < 6 cm), intermediate (6 cm ≤ ds ≤ 10 cm), and distant (10 cm ≤ ds). b) The reference MU value and c) the reference dose (Gy)
were presented as absolute values in parentheses. d) The patient group meeting the criteria of the PTV size, 3.5 cm ≤ dequi < 4.5 cm.
e) The patient group meeting the criteria of the PTV size, 4.5 cm ≤ dequi < 5.5 cm.
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Figure 5 Comparison of undulated dose distributions for angular increments in the patient cases. A predicted doses were calculated
using a 2-mm grid size and angular increments of (a) 2°, (b) 4°, (c) 6°, and (d) 10°.
Table 4 Comparison of the dose computation time (in the form of a ratio normalized to the time for the case of a
2-mm grid size and a 2° angular increment) in the phantom and patient cases for different plan parameter sets
Plan
parameters
Phantom Patients
G1 G2 G3
(3 cm ≤ dequi
a < 3.5 cm) (3.5 cm ≤ dequi < 4.5 cm), (4.5 cm ≤ dequi ≤ 5.5 cm)
ΔGrid ΔAngle S2
b S3 S4 P1 P2 P3 P4 P5 P6 P7 P8 P9
2 mm 2° 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
(08 min
45 s)
(09 min
17 s)
(10 min
04 s)
(09 min
45 s)
(11 min
33 s)
(09 min
59 s)
(13 min
44 s)
(10 min
49 s)
(10 min
26 s)
(10 min
34 s)
(11 min
54 s)
(12 min
23 s)
4° 0.51 0.52 0.50 0.51 0.51 0.55 0.51 0.51 0.51 0.50 0.51 0.51
6° 0.36 0.35 0.34 0.34 0.34 0.42 0.36 0.34 0.35 0.34 0.37 0.34
10° 0.22 0.21 0.21 0.20 0.21 0.26 0.21 0.20 0.22 0.21 0.22 0.21
3 mm 2° 0.45 0.47 0.46 0.44 0.42 0.44 0.41 0.44 0.35 0.42 0.43 0.42
4° 0.23 0.24 0.25 0.23 0.21 0.23 0.21 0.22 0.22 0.21 0.21 0.22
6° 0.16 0.16 0.17 0.15 0.16 0.15 0.15 0.14 0.16 0.14 0.16 0.14
10° 0.10 0.11 0.10 0.09 0.10 0.10 0.08 0.10 0.10 0.10 0.10 0.09
4 mm 2° 0.33 0.32 0.31 0.28 0.26 0.27 0.22 0.27 0.29 0.27 0.28 0.26
4° 0.16 0.16 0.17 0.14 0.13 0.14 0.13 0.16 0.14 0.15 0.14 0.13
6° 0.11 0.11 0.11 0.10 0.10 0.09 0.10 0.09 0.10 0.09 0.10 0.09
10° 0.07 0.07 0.07 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.05
a) The equivalent diameter of a sphere having the same volume as the planning target volume of patient cases b) Spherical targets of different sizes [S2 (2-cm
diameter), S3 (3-cm diameter), and S4 (4-cm diameter)].
Park et al. Radiation Oncology 2014, 9:5 Page 9 of 12
http://www.ro-journal.com/content/9/1/5
of 4°, 6°, and 10° reduced the calculation time by 49 ± 5%,
65 ± 3%, and 78 ± 2% in the phantom study and 48 ± 3%,
64 ± 3%, and 78 ± 2% in the patient study, respectively,
when the same grid size was used. With regard to using
an appropriate set of grid size and angular increment
parameters in the phantom and patient studies, a 3-mm
grid size and a 4° (6°) increment could provide dose dis-
tributions in a time that is reduced by 78% (85%) with
respect to that of the reference set of a 2-mm grid and a
2° increment.
Discussion and conclusions
The interpolated doses based on the coarser grid points
generally predicted lower doses than those predicted
based on finer grid points in high-dose gradient regions of
the generally prescribed isodose level (e.g., 60 to 90%)
[1,11]. In addition, the beam penumbra region shows a
steeper dose fall-off due to lateral electron disequilibrium,
when the small fields are irradiated [22]. Because under-
dosage around the PTV periphery becomes severe since
the effect of electron disequilibrium is critical when using
small fields, the dose error in the dose distribution
predicted using a coarser grid would be increased at high-
dose gradients. We were able to observe the largest dose
increase for the PTV and OARs in the plan for S2.
Niemierko and Goitein evaluated the accuracy of
interpolated doses by using linear interpolation accord-
ing to the grid size and a Fermi function presenting a
one-dimensional high-gradient dose profile for beam
penumbra [11]. They also described how large grid sizes
showed interpolated doses that were lower than the ref-
erence doses around the general prescribed isodose level.
A lower isodose level should be selected to deliver a
higher dose than the prescribed value to meet the PTV
dose and coverage [18]. We were able to compare the
prescribed isodose level according to the PTV size in a
planning system. Selecting a lower prescribed isodose
level owing to the lower dose estimated by using large
grid sizes required a larger number of MUs. Unintended
overdose might be delivered to the patients. This
phenomenon was also explored by Dempsey et al. by
showing lower PTV coverage for large grid sizes [23].
The discrete beam arrangement based on the angular
increment showed a jagged isodose distribution, which is
not expected in actual continuous beam delivery. Dose
undulation becomes severe as the interval between beam
axes increases with large angular increment [24]. As the
irradiated field size is decreased for smaller PTVs, the
probability that a small critical organ is located outside
of the fields would also increase. The larger angular
increment effect on structure doses was shown in the
plan for S2 in our study.
Because the discretized dose calculation based on the
dose mesh determined by the grid size and its errors are
inevitable in a treatment planning system, evaluation of
dose distributions with the predicted dose differences
according to the variable plan parameters is useful for
guiding appropriate plan parameters to achieve a balance
between accuracy and efficiency. The possible dose vari-
ation due to the angular increment should be considered
for OARs in serial tissue such as the spinal cord to avoid
unnecessary complications, as the spinal cord showed
the largest dose difference under the large angular incre-
ment. Sometimes, the spinal cord dose could be insig-
nificant, but even in those cases, it would be necessary
to get more accurate dose information for future use
such as for the case of either retreatment or treatment
of adjacent regions. As one of the alternative methods
for efficient dose computation in a planning system, we
can consider applying the small angular increment for
critical organs and a relatively large angular increment
for normal tissues.
We found that a plan parameter set consisting of a
3-mm grid size and a 4° angular increment is suitable
for the phantom study and a 3-mm grid size and a 6°
angular increment is suitable for patient cases. A phantom
study systemically evaluating the range of probable dose
differences under the angular increment effect showed
that a dose difference of 3% can occur even for spinal
cords at the same distance. We were able to observe
that one of the hypothetical spinal cords in the inter-
mediate and distant groups showed a dose difference
from the reference value of higher than 3%. This
could suggest that the dose difference on a small crit-
ical organ that is distant from the isocenter can be
higher than the acceptable dose error owing to the
slight difference in angular position although the dose
distributions were created for patients with structures
of similar size and anatomical geometry. The 3-mm
grid size and 4° angular increment would be more
appropriate for DCAT plans for lung SBRT.
To judge whether a 3-mm grid size and 10° angular
increment are applicable only to patients with proximal
spinal cords, we evaluated dose distributions in three
more patient cases with PTVs of different sizes and
proximal spinal cords. All evaluated PTV and OARs
doses also showed dose differences of less than 1%. We
might consider a 3-mm grid size and a 10° angular
increment for patients with all small OARs, such as the
spinal cord and esophagus, placed within a 6-cm dis-
tance from the isocenter. However, it might be difficult
to satisfy the dose constraint of spinal cord in lung
SBRT, as the spinal cord gets closer to the isocenter.
Dose evaluation of small OAR becomes more critical
even though the dose difference by the variable plan
parameters is insignificant. If we use the plan parameter
set of 3-mm grid size and 10° angular increment in dose
calculation for patients with a proximal small OAR in
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serial tissue type, maximum dose of the OAR should be
evaluated.
The use of a larger grid size and angular increment led
to a reduction in computation time. Although the dose
calculation is required for complex tissue composition in
patient studies, the time reduction ratio achieved by
applying variable plan parameter sets was similar in the
phantom and patient studies. When the large grid size is
used in the dose calculation, it was possible to reduce
the calculation time by approximately at a rate inverse
square of the grid sizes. We were also able to speed up
the dose calculation by a factor of the inverse ratio of
the number of beams for the larger grid size to the
number of beams for the reference case, for a par-
ticular angular increment. The appropriate plan par-
ameter set can be efficiently determined based on the
correlation of the dose calculation accuracy and the
time consumption.
Both DCAT and VMAT calculate and deliver optimal
planned doses during gantry rotation based on the
discrete beam configuration and dynamic MLC aper-
tures at each angular increment. While DCAT delivers
conformal doses using a relatively small number of
MUs, a constant dose rate, and MLC apertures corre-
sponding to the projection of the PTV at each angular
increment [9], VMAT provided a high dose gradient
using intensity modulation through a number of de-
liverable MLC segments converted from non-uniform
fluence optimized to satisfy the dose–volume constraints
of primary structures in inverse planning [12,24,25].
Under the case where various dynamic components,
such as gantry rotation speed, dose rate, and MLC leaf
moving speed, are synchronized, VMAT achieves con-
formal dose distributions. However, VMAT can have
more uncertainty when using an intensity modulation
technique, particularly for targets involved in significant
respiratory motion, owing to the systematic interplay
effect between the target motion and the beam aperture
motion, as demonstrated by Berbeco et al. [26]. Such un-
certainty is expected to be even larger under hypo-
fractionation treatment, which is typical in SBRT. In the
current health care system, the higher cost of VMAT
compared to DCAT is of concern for both billing and
human resource utilization. Thus, DCAT is the first
choice in our clinic, and VMAT is used only in situa-
tions in which it is very difficult to obtain an acceptable
dose distribution with DCAT. Examples of such situa-
tions include cases where multiple targets are close to-
gether, or when critical organs are located extremely
close to the target.
In general, it is not easy to predict dose errors for
OARs in advance with variable angular increments
[8,27]. The systematic evaluation of the dosimetric effect
of plan parameters on normal structures in different
positions would provide a reference to estimate the ap-
proximate error range in DCAT plans. The analysis of
dose variation as a function of plan parameters enabled
us to determine an optimal set of plan parameters to
achieve a balance between accuracy and efficiency in the
planning process. Under the conditions considered in
this study, a 3-mm grid size and a 4° angular increment
are suggested as an optimal set of planning parameters
for routine clinical practice with acceptable time effi-
ciency and without a significant compromise in dose ac-
curacy in DCAT.
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